Treating Alcohol Withdrawal With Oral Baclofen
NCT00597701 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79
Last updated 2011-07-27
Summary
The purpose of this study is determine if subjects with alcohol withdrawal who receive oral baclofen, plus standard benzodiazepine therapy, will experience less severe withdrawal symptoms than those who receive placebo plus standard benzodiazepine therapy.Subjects with alcohol withdrawal syndrome(AWS)who receive baclofen plus standard benzodiazepine therapy will experience fewer complications of AWS (as measured by use of additional sedatives, restraints, and/or intensive care unit \[ICU\] admissions) compared with subjects who receive placebo plus standard benzodiazepine therapy.
Conditions
- Alcohol Withdrawal Delirium
Interventions
- DRUG
-
Baclofen
Baclofen 10 mg by mouth every 8 hours for 72 hours or until discharge if before 72 hours.
- DRUG
-
Placebo
- DRUG
-
Lorazepam
Lorazepam was provided to all subjects (both arms of the study), as indicated by clinical condition. Standard "symptom-triggered dosing" of lorazepam for alcohol withdrawal was used. That is, the size and the frequency of the dose of lorazepam was determined by the severity of the alcohol withdrawal symptoms.
Sponsors & Collaborators
-
Essentia Health
lead OTHER
Principal Investigators
-
Jeffrey Lyon, MD · Essentia Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-04-30
- Primary Completion
- 2008-02-29
- Completion
- 2008-02-29
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Tolerability of Baclofen for Alcohol Dependence
NCT00877734 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Baclofen as Add-On to Standard Treatment of Alcohol- Dependent Patients
NCT01002105 ·Status: COMPLETED ·Phase: PHASE4
-
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
NCT02723383 ·Status: COMPLETED ·Phase: PHASE3
-
Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption
NCT06840652 ·Status: ENROLLING_BY_INVITATION
-
Drug Therapy for Alcohol Detoxification
NCT00000441 ·Status: COMPLETED ·Phase: PHASE4
-
Baclofen for the Treatment of Alcohol Dependence
NCT01266655 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of High Dose Baclofen for Alcohol Dependence
NCT01980706 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen for the Treatment of Alcohol Drinkers
NCT01604330 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
NCT00523185 ·Status: COMPLETED ·Phase: NA
-
Baclofen for Treating Anxiety and Alcoholism
NCT01751386 ·Status: COMPLETED ·Phase: PHASE2
-
Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease
NCT01711125 ·Status: COMPLETED ·Phase: PHASE3
-
Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder
NCT02596763 ·Status: TERMINATED ·Phase: PHASE4
-
ALK29-002: A Study of Baclofen Formulations in Healthy Adults
NCT00802035 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
NCT00373295 ·Status: COMPLETED ·Phase: PHASE2
-
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
NCT03586089 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Baclofen in the Treatment of Alcohol Addiction
NCT00525252 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phenobarbital for Acute Alcohol Withdrawal
NCT01184417 ·Status: COMPLETED ·Phase: NA
-
GABA-B Receptor Function in Healthy Volunteers
NCT01563224 ·Status: COMPLETED ·Phase: NA
-
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
NCT00011297 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam
NCT00229125 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
NCT05438641 ·Status: COMPLETED
-
Impact of a One-month Long Detoxification Diazepam Treatment on Early Alcohol Relapse
NCT02242955 ·Status: COMPLETED ·Phase: NA
-
A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
NCT01076283 ·Status: COMPLETED ·Phase: PHASE2
-
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine
NCT03788889 ·Status: WITHDRAWN ·Phase: PHASE4
-
Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
NCT00721526 ·Status: COMPLETED ·Phase: PHASE4